Trupanion Stock Forecast, Price & News

Trupanion's stock was trading at $26.04 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, TRUP stock has increased by 344.2% and is now trading at $115.66.
View which stocks have been most impacted by COVID-19.

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Trupanion in the last year. There are currently 4 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Trupanion stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TRUP, but not buy additional shares or sell existing shares.
View analyst ratings for Trupanion or view MarketBeat's top 5 stock picks.

Wall Street analysts have given Trupanion a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Trupanion wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

1,448 employees have rated Trupanion CEO Doug Parker on Glassdoor.com. Doug Parker has an approval rating of 60% among Trupanion's employees. This puts Doug Parker in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Trupanion is scheduled to release its next quarterly earnings announcement on Thursday, February 11th 2021.
View our earnings forecast for Trupanion.

Trupanion, Inc. (NASDAQ:TRUP) announced its quarterly earnings data on Thursday, October, 29th. The financial services provider reported ($0.07) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.04) by $0.03. The financial services provider earned $130.12 million during the quarter, compared to analyst estimates of $126.53 million. Trupanion had a negative return on equity of 1.22% and a negative net margin of 0.37%. Trupanion's quarterly revenue was up 31.1% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.02 earnings per share.
View Trupanion's earnings history.

7 Wall Street analysts have issued 1-year price targets for Trupanion's shares. Their forecasts range from $40.00 to $95.00. On average, they anticipate Trupanion's share price to reach $62.60 in the next twelve months. This suggests that the stock has a possible downside of 45.9%.
View analysts' price targets for Trupanion or view Wall Street analyst' top-rated stocks.

Some companies that are related to Trupanion include UnitedHealth Group (UNH), Cigna (CI), Anthem (ANTM), Humana (HUM), Centene (CNC), Molina Healthcare (MOH), Clover Health Investments (CLOV) and Advanzeon Solutions (CHCR).
View all of TRUP's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Trupanion investors own include CA (CA), Micron Technology (MU), Chipotle Mexican Grill (CMG), McEwen Mining (MUX), Pfizer (PFE), Splunk (SPLK), AbbVie (ABBV), Abbott Laboratories (ABT), Advanced Micro Devices (AMD) and Activision Blizzard (ATVI).

Trupanion trades on the NASDAQ under the ticker symbol "TRUP."

Trupanion's stock is owned by a variety of retail and institutional investors. Top institutional investors include Frontier Capital Management Co. LLC (0.20%), State of Alaska Department of Revenue (0.07%), Louisiana State Employees Retirement System (0.04%), Hamilton Lane Advisors LLC (0.03%), Crossmark Global Holdings Inc. (0.02%) and First Hawaiian Bank (0.02%). Company insiders that own Trupanion stock include Asher Bearman, Dan Levitan, Darryl Rawlings, Gavin Friedman, H Hays Lindsley, Howard E Rubin, Margaret Tooth, Michael Doak, Murray B Low, Robin A Ferracone and Tricia Plouf.
View institutional ownership trends for Trupanion.

TRUP stock was sold by a variety of institutional investors in the last quarter, including Hamilton Lane Advisors LLC, Frontier Capital Management Co. LLC, State of Alaska Department of Revenue, and First Hawaiian Bank. Company insiders that have sold Trupanion company stock in the last year include Asher Bearman, Dan Levitan, Darryl Rawlings, Gavin Friedman, H Hays Lindsley, Howard E Rubin, Margaret Tooth, Michael Doak, Murray B Low, Robin A Ferracone, and Tricia Plouf.
View insider buying and selling activity for Trupanion or view top insider-selling stocks.

TRUP stock was purchased by a variety of institutional investors in the last quarter, including Crossmark Global Holdings Inc., Vivid Financial Management Inc., and Louisiana State Employees Retirement System.
View insider buying and selling activity for Trupanion or or view top insider-buying stocks.

Shares of TRUP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of TRUP stock can currently be purchased for approximately $115.66.

Trupanion has a market capitalization of $4.12 billion and generates $383.94 million in revenue each year. The financial services provider earns $-1,810,000.00 in net income (profit) each year or ($0.05) on an earnings per share basis. Trupanion employs 738 workers across the globe.

The official website for Trupanion is www.trupanion.com.

Trupanion's mailing address is 6100 4TH AVENUE SOUTH SUITE 200, SEATTLE WA, 98108. The financial services provider can be reached via phone at 855-727-9079 or via email at [email protected]